Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Rajiv Arya who wrote (275)	6/24/1999 3:54:00 PM
From: Dan Hamilton	Respond to of 500

These biventricular pacemaker devices have been in development for awhile, like LVADs. I have a market report on them at home, and can post some information later tomorrow or over the weekend. I recall that they target earlier stage heart failure than do the LVADs and hence will not directly compete for some time to come. Eventually they likely will, but there are unfortunately more than enough patients to go around for both types of technologies. So, to answer your question, I do not believe this news release would have much effect on WHT.